A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients
Sponsor: GlaxoSmithKline
Listed as NCT01728428, this observational or N/A phase trial focuses on Hemifacial Spasm and remains completed. Sponsored by GlaxoSmithKline, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Aug 2018 — Jan 2021 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
- Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .